Senior Research Associate

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE

ctDNA monitoring using patient-specific sequencing and integration of variant reads.

E-pub date: 31 May 2020

Enhanced detection of circulating tumor DNA by fragment size analysis.

E-pub date: 31 Oct 2018

Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients.

E-pub date: 31 Jul 2018

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.

E-pub date: 16 Mar 2018

Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.

E-pub date: 15 Mar 2018

Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.

E-pub date: 01 Apr 2017

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

E-pub date: 31 Dec 2016

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer.

E-pub date: 04 Nov 2015

Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.

E-pub date: 01 Feb 2015

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.

E-pub date: 02 May 2013

Analysis of circulating tumor DNA to monitor metastatic breast cancer.

E-pub date: 28 Mar 2013

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

E-pub date: 30 May 2012

Show all
Research Integrity Conflict of Interest Disclosure: 
Last revised: 
Company Active Research funding Ownership Royalty payments Commitment to carry out work for a fee Ad hoc reimbursed work Travel Gifts/ other
Inivata Ltd No No Yes No No No No No
Disclosure guidelines